HHealthcare Read More FDA Pulls Warning Labels From Hormone Replacement TherapiesNovember 11, 2025 Hormone replacement therapies used to treat menopause symptoms no longer need to carry strict warnings about some potential…
MMedication Read More Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in StudyNovember 6, 2025 Metsera Inc.’s next-generation weight-loss drug showed good tolerability with few participants dropping out of a mid-stage trial, adding…
HHealthcare Read More Lilly, Novo to Lower Obesity Drug Prices in Deal with TrumpNovember 6, 2025 Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for…
HHealthcare Read More Metsera calls Novo Nordisk’s new bid superior to Pfizer offerNovember 4, 2025 The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy…
HHealth Read More US, Canada Face Loss of Measles Elimination Status by WHONovember 4, 2025 Hi, it’s Jessica in Washington. A key meeting starts today that will decide measles elimination status for the…
HHealthcare Read More Pfizer files second lawsuit against Novo Nordisk, MetseraNovember 3, 2025 A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California,…
HHealthcare Read More Pfizer sues Metsera, Novo Nordisk over rival obesity drug bidNovember 1, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer said on Friday it had filed a lawsuit against Metsera and Novo…
MMedication Read More Why an Old Multiple Sclerosis Drug Costs More Than Ever in the USOctober 30, 2025 When Jean Kay started a brand-new multiple sclerosis treatment called Rebif in 2003, it cost $17,500 a year.…
HHealthcare Read More Pfizer’s Q3 2025 Earnings: What to ExpectOctober 19, 2025 With a market cap of $139.4 billion, Pfizer Inc. (PFE) is a global biopharmaceutical company headquartered in New York, known…
HHealthcare Read More Pfizer’s Deal on Drug Prices Is Good But Deserves ScrutinyOctober 10, 2025 American taxpayers spend billions of dollars annually supporting pharmaceutical development. Yet the US continues to pay more for…
MMarkets Read More What’s likely to move the market in the next trading sessionOctober 2, 2025 Stocks @ Night is a daily newsletter delivered after hours, giving you a first look at tomorrow and…
HHealthcare Read More Pfizer’s new obesity bet, Metsera, releases drug dataSeptember 30, 2025 Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in…